Recreational cannabis has officially been legalized in Delaware.
Delaware became the 22nd state to legalize recreational cannabis in April 2023. While many celebrated cannabis’s liberation, not everyone was on board. One of these individuals being their governor (1).
The medicinal plant became legal for individuals over the age of 21. Governor John Carney (D) mentioned he still doesn’t support the recreastional use of cannabis but that the focus at the state level needs to fall to other issues. Gov. Carney has some fears for safety on roadways, children, and in poorer neighborhoods.
Delaware has not established dispensaries throughout the state yet. One bill that passed state legislature can create state-led regulations and licensing for manufacturing, cultivation, and retail.
Aside from Delaware, over 20 states have legalized recreational use. In New Jersey, cannabis sales have totaled over $228 million in 2022. Their state cannabis regulatory commission stated that the plant brought in nearly $20 million in tax revenue. The state of Delaware does not have a sales tax, which causes some uncertainty on how the state’s finances could be effected (1).
With cannabis legalized in Delaware, Pennsylvania is the now the only state in the Philly region who has not yet legalized cannabis. In Philadelphia, having a small amount of the plant has been decriminalized. All eyes are shifting to Pennsylvania to see if they will be next to approve of recreational use.
Reference
Ep 24, Part I: Data Transparency in Cannabis Testing with Yasha Khan
November 21st 2024Evan Friedmann interviews Yasha Khan, co-founder of MCR Labs, about his journey into the cannabis industry and his efforts to promote transparency and integrity in laboratory practices. Yasha discusses the origins of MCR Labs, which began in Massachusetts to meet the needs of the soon-to-be legal medical cannabis market. He explains the challenges faced, including result manipulation by labs and the impact on public health. Yasha's Freedom of Information Act (FOIA) project aimed to gather testing data from 37 states, revealed significant discrepancies in potency and mold results. Despite some states' reluctance to share data, Yasha has made much of this data public, leading to collaborative research and publications on various aspects of cannabis testing.
Assessing Cannabis as a Harm Reduction Strategy: Insights from a Large-Scale Study
November 19th 2024A New Zealand study aimed to assess cannabis use as a harm reduction tool. Findings highlight lifestyle factors, and suggest cannabis-focused harm reduction strategies in reducing other substance use such as alcohol.
Ep 23, Part III: Accreditation in the Cannabis Industry with Susan Audino
October 24th 2024In Part III of this episode, host Evan Friedmann is joined by Susan Audino, PhD, founder of S.A. Audino & Associates, LLC, and co-founder of Saturn Scientific, LLC, to examine the complexities of sampling in the cannabis industry, emphasizing the need for proper sampling plans, and methods.